We are live on ! Find out more
ESLAW icon

Estrella Immunopharma Warrant
ESLAW

7 hedge funds and large institutions have $4.52M invested in Estrella Immunopharma Warrant in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ASM
ATW SPAC Management
New York
+$80K
2
BFM
Boothbay Fund Management
New York
+$80K
3
KPF
K2 Principal Fund
Ontario, Canada
+$59K
4
CH
CVI Holdings
Delaware
+$35.9K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$35.9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ASM
1
ATW SPAC Management
New York
$1.93M +$80K +195,000 New
BFM
2
Boothbay Fund Management
New York
$1.93M +$80K +195,000 New
RCM
3
Radcliffe Capital Management
Pennsylvania
$495K +$20.5K +50,000 New
KPF
4
K2 Principal Fund
Ontario, Canada
$59K +$59K +143,947 New
CH
5
CVI Holdings
Delaware
$36K +$35.9K +87,500 New
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$36K +$35.9K +87,500 New
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$34K +$33.8K +82,500 New

ESLAW Hedge Fund Activity: Q3 2021 in Review

7 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q3 2021, worth a combined $4.52M.

Buyers outnumbered sellers: 7 funds opened new ESLAW positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was ATW SPAC Management, opening a new position worth an estimated $80K.

  • 7 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $4.52M of Estrella Immunopharma Warrant stock for Q3 2021.
  • 7 funds opened new Estrella Immunopharma Warrant positions in Q3 2021 and 0 closed out, a net change of +7 holders.
  • The largest Estrella Immunopharma Warrant buyer in Q3 2021 was ATW SPAC Management, an estimated $80K added.

Based on aggregated 13F filings for Q3 2021.